10X GENOMICS, INC.

TXG
Exchange NMS, Currency in USD
Loading price...

Overview

Previous Close18.79
Open19.12
Ask16.73
Bid16.63
Day's Range15.90 - 19.27
52 Week Range6.78 - 23.56
PE Ratio(TTM)--
Market Cap2.13B
Volume5.58M
Avg. Volume2.49M
12 Months Earnings-239.78M
12 Months Revenue631.73M

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARSTTM2023202220212020
Operating Revenue631.73M618.73M516.41M490.49M298.85M
Cost of Revenue223.29M209.41M120.39M74.09M58.47M
Gross Profit408.44M409.31M396.02M416.40M240.38M
Operating Expenses661.66M674.64M563.97M469.31M773.25M
Profit after Tax (Net Income)-239.78M-255.10M-166.00M-58.22M-542.73M

Company Profile

Sector: Healthcare
Industry: Health Information Services
HQ Location: Pleasanton, United States
Website: https://www.10xgenomics.com
Co-Founder, CEO & Director: Dr. Serge Saxonov Ph.D.
Employees: 1,178
About Company:
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
DISCLAIMER: Stock prices are not real time and the delay can range from a few seconds to several minutes. The data displayed are solely for informational purposes, not for trading purposes or advice.